SCD CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,481 KRW | -0.87% |
|
-0.87% | -15.52% |
| Apr. 03 | Schroder European Real Estate Investment Trust Refinances EUR9 Million Loan | MT |
| Feb. 01 | SeaStar Medical Gets Canadian Patent Covering Technology for Cell-Directed Therapy | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 54,129 | 63,795 | 81,194 | 87,477 | 88,685 | 84,722 |
| Enterprise Value (EV) 1 | 14,029 | 24,084 | 31,185 | 38,511 | 30,691 | 23,075 |
| P/E ratio | 6.92 x | -62.9 x | 21.6 x | 12.7 x | 10.7 x | 17.5 x |
| Yield | 2.68% | 1.14% | 1.19% | 1.66% | 1.91% | - |
| Capitalization / Revenue | 0.34 x | 0.36 x | 0.43 x | 0.43 x | 0.41 x | 0.44 x |
| EV / Revenue | 0.09 x | 0.14 x | 0.16 x | 0.19 x | 0.14 x | 0.12 x |
| EV / EBITDA | 1.72 x | 3.59 x | 3.76 x | 3.24 x | 2.17 x | 2.79 x |
| EV / FCF | -5.87 x | 5.25 x | 3.29 x | -12.3 x | 2.51 x | 17.9 x |
| FCF Yield | -17% | 19.1% | 30.4% | -8.11% | 39.8% | 5.59% |
| Price to Book | 0.53 x | 0.63 x | 0.78 x | 0.78 x | 0.74 x | 0.7 x |
| Nbr of stocks (in thousands) | 48,330 | 48,330 | 48,330 | 48,330 | 48,330 | 48,330 |
| Reference price 2 | 1,120 | 1,320 | 1,680 | 1,810 | 1,835 | 1,753 |
| Announcement Date | 3/21/19 | 3/27/20 | 3/22/21 | 3/22/22 | 3/23/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 159,269 | 174,946 | 190,842 | 202,170 | 218,909 | 193,993 |
| EBITDA 1 | 8,157 | 6,702 | 8,283 | 11,895 | 14,147 | 8,269 |
| EBIT 1 | 4,938 | 3,478 | 5,215 | 9,122 | 11,333 | 5,748 |
| Operating Margin | 3.1% | 1.99% | 2.73% | 4.51% | 5.18% | 2.96% |
| Earnings before Tax (EBT) 1 | 9,898 | -1,299 | 5,168 | 8,737 | 11,241 | 8,489 |
| Net income 1 | 7,824 | -992.1 | 3,753 | 6,932 | 8,297 | 4,842 |
| Net margin | 4.91% | -0.57% | 1.97% | 3.43% | 3.79% | 2.5% |
| EPS 2 | 161.9 | -21.00 | 77.65 | 143.0 | 171.7 | 100.0 |
| Free Cash Flow 1 | -2,390 | 4,591 | 9,475 | -3,125 | 12,205 | 1,289 |
| FCF margin | -1.5% | 2.62% | 4.96% | -1.55% | 5.58% | 0.66% |
| FCF Conversion (EBITDA) | - | 68.5% | 114.39% | - | 86.28% | 15.59% |
| FCF Conversion (Net income) | - | - | 252.47% | - | 147.11% | 26.62% |
| Dividend per Share 2 | 30.00 | 15.00 | 20.00 | 30.00 | 35.00 | - |
| Announcement Date | 3/21/19 | 3/27/20 | 3/22/21 | 3/22/22 | 3/23/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 40,100 | 39,711 | 50,009 | 48,965 | 57,994 | 61,647 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -2,390 | 4,591 | 9,475 | -3,125 | 12,205 | 1,289 |
| ROE (net income / shareholders' equity) | 7.83% | -0.98% | 3.68% | 6.45% | 7.19% | 4.02% |
| ROA (Net income/ Total Assets) | 2.47% | 1.62% | 2.21% | 3.56% | 4.28% | 2.15% |
| Assets 1 | 316,531 | -61,226 | 169,964 | 194,582 | 193,874 | 224,870 |
| Book Value Per Share 2 | 2,120 | 2,083 | 2,140 | 2,310 | 2,468 | 2,496 |
| Cash Flow per Share 2 | 350.0 | 825.0 | 1,039 | 1,016 | 1,202 | 1,267 |
| Capex 1 | 3,022 | 3,170 | 1,254 | 3,779 | 2,699 | 3,357 |
| Capex / Sales | 1.9% | 1.81% | 0.66% | 1.87% | 1.23% | 1.73% |
| Announcement Date | 3/21/19 | 3/27/20 | 3/22/21 | 3/22/22 | 3/23/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -15.52% | 52.03M | |
| +25.92% | 29.4B | |
| +45.96% | 7.49B | |
| +79.56% | 6.38B | |
| -20.42% | 5.29B | |
| +10.23% | 3.64B | |
| +33.62% | 3.08B | |
| +4.80% | 3.07B | |
| -6.34% | 2.85B | |
| +9.50% | 3.11B |
- Stock Market
- Equities
- A042110 Stock
- Financials SCD Co., Ltd.
